title: Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
abstract: The high mobility group A1 gene (HMGA1) has been previously implicated in breast carcinogenesis, and is considered an attractive target for therapeutic intervention because its expression is virtually absent in normal adult tissue. Other studies have shown that knockdown of HMGA1 reduces the tumorigenic potential of breast cancer cells in vitro. Therefore, we sought to determine if silencing HMGA1 can affect breast cancer development and metastatic progression in vivo. We silenced HMGA1 expression in the human breast cancer cell line MDA-MB-231 using an RNA interference vector, and observed a significant reduction in anchorage-independent growth and tumorsphere formation, which respectively indicate loss of tumorigenesis and self-renewal ability. Moreover, silencing HMGA1 significantly impaired xenograft growth in immunodeficient mice, and while control cells metastasized extensively to the lungs and lymph nodes, HMGA1-silenced cells generated only a few small metastases. Thus, our results show that interfering with HMGA1 expression reduces the tumorigenic and metastatic potential of breast cancer cells in vivo, and lend further support to investigations into targeting HMGA1 as a potential treatment for breast cancer.
authors.affiliation: Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. fdicello@hotmail.com
authors.forename: Francescopaolo
authors.initials: F
authors.lastname: Di Cello
authors.forename: James
authors.initials: J
authors.lastname: Shin
authors.forename: Kirsten
authors.initials: K
authors.lastname: Harbom
authors.forename: Cory
authors.initials: C
authors.lastname: Brayton
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D005260:Female; D055785:Gene Knockdown Techniques; D025741:HMGA1a Protein / Q000037:antagonists & inhibitors* / Q000235:genetics*; D006801:Humans; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D018874:Spheroids, Cellular / Q000473:pathology; D014183:Transplantation, Heterologous / Q000473:pathology
chemical_list: D025741:HMGA1a Protein
references.citation: Histol Histopathol. 2003 Oct;18(4):999-1004
references.pmid: 12973668
references.citation: Biochim Biophys Acta. 2001 May 28;1519(1-2):13-29
references.pmid: 11406267
references.citation: Cancer Res. 1998 Sep 15;58(18):4193-8
references.pmid: 9751634
references.citation: Mod Pathol. 2010 Jan;23(1):98-104
references.pmid: 19820691
references.citation: Cancer Res. 2004 May 15;64(10):3371-5
references.pmid: 15150086
references.citation: Cancer Res. 2007 May 1;67(9):3998-4004
references.pmid: 17483309
references.citation: J Surg Oncol. 2004 Nov 1;88(2):86-99
references.pmid: 15499602
references.citation: Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):48-54
references.pmid: 20123067
references.citation: Breast Care (Basel). 2010;5(2):81-85
references.pmid: 20847819
references.citation: Cancer Res. 2005 Jul 1;65(13):5506-11
references.pmid: 15994920
references.citation: Nat Rev Cancer. 2007 Dec;7(12):899-910
references.pmid: 18004397
references.citation: Mol Cell Biol. 2001 Jan;21(2):575-94
references.pmid: 11134344
references.citation: Clin Cancer Res. 2004 Nov 15;10(22):7637-44
references.pmid: 15569996
references.citation: Cancer Res. 1993 Nov 15;53(22):5512-6
references.pmid: 8221692
references.citation: Breast Cancer Res Treat. 2002 Feb;71(3):181-91
references.pmid: 12002338
references.citation: Carcinogenesis. 2003 Jul;24(7):1191-8
references.pmid: 12807722
references.citation: Mol Cancer Res. 2009 Nov;7(11):1803-12
references.pmid: 19903768
references.citation: Acta Otolaryngol. 2007 Jan;127(1):76-81
references.pmid: 17364334
references.citation: Cancer Res. 2010 Jan 15;70(2):436-9
references.pmid: 20068164
references.citation: Int J Cancer. 2001 Jan 15;91(2):147-51
references.pmid: 11146437
references.citation: Eur J Cancer. 2013 Apr;49(6):1374-403
references.pmid: 23485231
references.citation: BMC Genomics. 2011 Nov 04;12:549
references.pmid: 22053823
references.citation: J Cell Sci. 2011 Oct 1;124(Pt 19):3189-97
references.pmid: 21940791
references.citation: Genes Dev. 2003 May 15;17(10):1253-70
references.pmid: 12756227
references.citation: Cancer Res. 2000 Jun 15;60(12):3117-22
references.pmid: 10866296
references.citation: Cancer Res. 1999 Nov 15;59(22):5695-703
references.pmid: 10582687